Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
WCCB CharlotteBy Associated PressNovember 2, 2026
Originally published by WCCB Charlotte. The summary below is provided for informational purposes. Read the full article on their website.
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.
Read the complete story on the original publisher's website
Read the Full Story at WCCB Charlotte